HTB South

Women’s health

Featured Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART

Women, HIV research and antiretrovirals

Improved virological outcomes for women starting efavirenz-based first-line regimens in South Africa

High rates of pregnancy in HIV positive women in Zambia and South Africa

Contraceptive choices among a Canadian cohort of HIV positive women

Bone disease and older HIV positive women

Lower immune response to the qHPV vaccine in HIV positive girls

Nevirapine-containing ART does not reduce combined oral contraceptive effectiveness

Minimal risk of sexual HIV transmission for heterosexual couples when the HIV positive partner has an undetectable viral load

Differences by age for women in response to initial ART: meta-analysis from clinical studies submitted to the FDA

Lopinavir/ritonavir in pregnancy: results from a systematic review

Possible mechanisms for adverse pregnancy outcomes in HIV positive women

Hormonal contraception and the risk of HIV acquisition

Hormonal contraception: HIV transmission and progression rates

Darunavir use during pregnancy

The effect of BMI on efficacy, safety and tolerability of lopinavir/r in women

Hormonal contraception and higher risk of non-AIDS-defining events in Nashville cohort

Lopinavir/ritonavir: women versus men

Quality of life in the GRACE study

Antiretroviral pharmacokinetics in women with undetectable viral load

No association between bone mineral density and lipodystrophy in women receiving antiretroviral therapy

The impact of antiretroviral treatment on fertility intentions in South Africa

Efavirenz-based regimens among women of reproductive age receiving ART in Johannesburg

Gender-based differences in patients receiving antiretroviral therapy

No clinically relevant interactions between TMC278 and oral contraceptives (norethindrone plus ethinylestradiol)

Etravirine pregnancy data from five cases: no dose adjustment required

Gender and race differences in lipodystrophy symptoms

Pregnancy rates and outcomes among women in the DART trial

A cost-effectiveness analysis of the OCTANE trial

Results from HSV-2 acyclovir studies

No effect of hormonal contraception on HIV disease progression in large multi-country cohort

Progression and regression of pre-malignant cervical lesions in HIV-positive women from Soweto

HAART suppresses genital tract HIV shedding in HIV/HSV co-infected women

Efavirenz significantly reduces levels of some oral contraceptives

The unmet need for contraception services for women receiving ART

Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women

HPV genotypes in HIV-positive women in Zimbabwe and Uganda